While expression of DBNDD2 messenger (m) RNA was lower in all cancer types (Figure 2B), expression of the DBNDD1 gene was significantly higher in numerous tumor types, including PCa, lung cancer, and liver cancer, among others (Figure 2C). This evidence concerns the gene DBNDD1 and posterior cortical atrophy.